The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy
<i>Background and Objectives</i>: Protease activated receptor-2 (PAR2) is elevated in a variety of cancers and has been promoted as a potential therapeutic target. However, the clinical and prognostic values of PAR2 in hepatocellular carcinoma (HCC) are poorly characterized. This study a...
Main Authors: | Ming-Chao Tsai, Chih-Che Lin, Ding-Wei Chen, Yueh-Wei Liu, Yi-Ju Wu, Yi-Hao Yen, Pao-Yuan Huang, Chih-Chien Yao, Ching-Hui Chuang, Chang-Chun Hsiao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/57/6/574 |
Similar Items
-
Clinicopathological Distinction of Low-AFP-Secreting vs. High-AFP-Secreting Hepatocellular Carcinomas
by: Ahmet Gurakar, et al.
Published: (2018-11-01) -
Development And Validation Of A Simple Model For Detection Of Early Hepatocellular Carcinoma In A Liver Cirrhosis Cohort
by: Li T, et al.
Published: (2019-11-01) -
RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma
by: Heng-Yuan Hsu, et al.
Published: (2017-11-01) -
Hepatocellular carcinoma: microstructure and expression features of hepatocyte marker, alphafetoprotein, cytokeratins 7 and 20
by: V. A. Tumanskiy, et al.
Published: (2014-04-01) -
Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
by: Ming-Chao Tsai, et al.
Published: (2019-12-01)